248 related articles for article (PubMed ID: 18512025)
41. Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures.
Lokhorst HM; Lamme T; de Smet M; Klein S; de Weger RA; van Oers R; Bloem AC
Blood; 1994 Oct; 84(7):2269-77. PubMed ID: 7919345
[TBL] [Abstract][Full Text] [Related]
42. Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: a possible role for HGF in myeloma-associated osteolytic bone disease.
Hjertner O; Torgersen ML; Seidel C; Hjorth-Hansen H; Waage A; Børset M; Sundan A
Blood; 1999 Dec; 94(11):3883-8. PubMed ID: 10572104
[TBL] [Abstract][Full Text] [Related]
43. Positive and negative cooperativity of TNF and Interferon-γ in regulating synovial fibroblast function and B cell survival in fibroblast/B cell co-cultures.
Lowin T; Anssar TM; Bäuml M; Classen T; Schneider M; Pongratz G
Sci Rep; 2020 Jan; 10(1):780. PubMed ID: 31964950
[TBL] [Abstract][Full Text] [Related]
44. Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines.
Kim I; Uchiyama H; Chauhan D; Anderson KC
Br J Haematol; 1994 Jul; 87(3):483-93. PubMed ID: 7993788
[TBL] [Abstract][Full Text] [Related]
45. The role of interleukin-1 and tumour necrosis factor-alpha in human multiple myeloma.
Carter A; Merchav S; Silvian-Draxler I; Tatarsky I
Br J Haematol; 1990 Apr; 74(4):424-31. PubMed ID: 2346722
[TBL] [Abstract][Full Text] [Related]
46. In vitro neural differentiation of bone marrow stromal cells induced by hepatocyte growth factor and glial cell derived neurotrophic factor.
Ma Q; Cai M; Shang JW; Yang J; Gu XY; Liu WB; Yang Q
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4654-4663. PubMed ID: 27906439
[TBL] [Abstract][Full Text] [Related]
47. Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis.
Lwin T; Crespo LA; Wu A; Dessureault S; Shu HB; Moscinski LC; Sotomayor E; Dalton WS; Tao J
Leukemia; 2009 Jan; 23(1):170-7. PubMed ID: 18843286
[TBL] [Abstract][Full Text] [Related]
48. Cytokine profile in multiple myeloma.
Jasrotia S; Gupta R; Sharma A; Halder A; Kumar L
Cytokine; 2020 Dec; 136():155271. PubMed ID: 32916474
[TBL] [Abstract][Full Text] [Related]
49. Role of interleukin 16 in multiple myeloma.
Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
[TBL] [Abstract][Full Text] [Related]
50. Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation.
Atkins GJ; Haynes DR; Geary SM; Loric M; Crotti TN; Findlay DM
Bone; 2000 Jun; 26(6):653-61. PubMed ID: 10831938
[TBL] [Abstract][Full Text] [Related]
51. Production of cytokines by bone marrow cells obtained from patients with multiple myeloma.
Lichtenstein A; Berenson J; Norman D; Chang MP; Carlile A
Blood; 1989 Sep; 74(4):1266-73. PubMed ID: 2475182
[TBL] [Abstract][Full Text] [Related]
52. The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients.
Cao Y; Luetkens T; Kobold S; Hildebrandt Y; Gordic M; Lajmi N; Meyer S; Bartels K; Zander AR; Bokemeyer C; Kröger N; Atanackovic D
Exp Hematol; 2010 Oct; 38(10):860-7. PubMed ID: 20619313
[TBL] [Abstract][Full Text] [Related]
53. Pituitary adenylate cyclase-activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cells.
Li M; Cortez S; Nakamachi T; Batuman V; Arimura A
Cancer Res; 2006 Sep; 66(17):8796-803. PubMed ID: 16951196
[TBL] [Abstract][Full Text] [Related]
54. [Effects of normal human bone marrow fibroblastoid stromal cell line on the proliferation of multiple myeloma cell line RPMI8226].
Jin XQ; Bai QX; Liang R; Chen XQ; Huang GS; Dong BX; Zhang WP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):475-9. PubMed ID: 15363135
[TBL] [Abstract][Full Text] [Related]
55. Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients.
Le Meur Y; Lorgeot V; Aldigier JC; Wijdenes J; Leroux-Robert C; Praloran V
Nephrol Dial Transplant; 1999 Oct; 14(10):2420-6. PubMed ID: 10528667
[TBL] [Abstract][Full Text] [Related]
56. Hepatocyte growth factor is constitutively produced by human bone marrow stromal cells and indirectly promotes hematopoiesis.
Takai K; Hara J; Matsumoto K; Hosoi G; Osugi Y; Tawa A; Okada S; Nakamura T
Blood; 1997 Mar; 89(5):1560-5. PubMed ID: 9057637
[TBL] [Abstract][Full Text] [Related]
57. Novel therapies targeting the myeloma cell and its bone marrow microenvironment.
Hideshima T; Chauhan D; Podar K; Schlossman RL; Richardson P; Anderson KC
Semin Oncol; 2001 Dec; 28(6):607-12. PubMed ID: 11740818
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells.
Lin X; Yang L; Wang G; Zi F; Yan H; Guo X; Chen J; Chen Q; Huang X; Li Y; Zhang E; Wu W; Yang Y; He D; He J; Cai Z
Oncotarget; 2017 Nov; 8(54):92841-92854. PubMed ID: 29190960
[TBL] [Abstract][Full Text] [Related]
59. [Growth, immunophenotype and interleukin-6 level of bone marrow stromal cells in patients with multiple myeloma and acute leukemia].
Zhuang JL; Wang X; Zhang JP; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):700-3. PubMed ID: 16928303
[TBL] [Abstract][Full Text] [Related]
60. Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma.
Tai YT; Li X; Tong X; Santos D; Otsuki T; Catley L; Tournilhac O; Podar K; Hideshima T; Schlossman R; Richardson P; Munshi NC; Luqman M; Anderson KC
Cancer Res; 2005 Jul; 65(13):5898-906. PubMed ID: 15994968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
